Abordaje integral de la Interrupción Voluntaria del Embarazo: (segunda entrega)
Crimer, Nicole; Lo Sasso, Alejandrina.
Evid. actual. práct. ambul
; 25(3): e007022, 2022. tab
Artigo em Espanhol | LILACS, UNISALUD, BINACIS | ID: biblio-1398129
Documentos relacionados
Dosing interval between mifepristone and misoprostol in second and third trimester termination.
Mifepristone and Misoprostol for Early Pregnancy Loss and Medication Abortion.
Access to mifepristone, misoprostol, and contraceptive medicines in eight countries in the Eastern Mediterranean Region: descriptive analyses of country-level assessments.
Early medical abortion with self-administered low-dose mifepristone in combination with misoprostol.
Expulsion at home for early medical abortion: A systematic review with meta-analyses.
"In patient" medical abortion versus surgical abortion: patient's satisfaction.
Mifepristone and misoprostol compared with misoprostol alone for induction of labor in intrauterine fetal death: A randomized trial.
Short versus Standard Mifepristone and Misoprostol Regimen for Second- and Third-Trimester Termination of Pregnancy for Fetal Anomaly.
Outcomes During Early Implementation of Mifepristone-Buccal Misoprostol Abortions up to 63 Days of Gestation in a Canadian Clinical Setting.
Management of pain associated with up-to-9-weeks medical termination of pregnancy (MToP) using mifepristone-misoprostol regimens: expert consensus based on a systematic literature review.